BlueWind Medical

Exciting news for CY2025! CMS has raised the national unadjusted ASC payment rate for Category III CPT code 0817T (which includes the Revi® System) by 40%, now set at $19,839. In the Hospital Outpatient setting, the rate has also increased by 3%, reaching $21,444.   These adjustments underscore CMS’s recognition of the Revi System's unique clinical benefits as a minimally invasive and effective solution for treating urgency urinary incontinence (#UUI).   Learn more: https://lnkd.in/eDF_9mgA #Urology #PatientCare

Happy Holidays from the BlueWind Medical team! We’re grateful for the opportunity to support providers in delivering care to urge urinary incontinence patients. Here’s to an impactful year ahead! #Urogyn #Urology #UUI

We have shared some exciting announcements throughout the year for The Revi® System, including: 👉 Inclusion in AUA/SUFU Guidelines 👉 New 2-year multi-center data supporting The Revi® System 👉 The publication of a comprehensive meta-analysis in the October issue of the peer-reviewed publication, Advances in Therapy 👉 Announcement of Favorable CMS Decision for 2025 Reimbursement Rates for Revi System’s Implantable Tibial Neuromodulation Therapy Watch the video for key takeaways and visit our new publications and guidelines webpage to learn more: https://lnkd.in/eMGsFCSM #Urology #OAB #ClinicalResearch

Dr. Suzette Sutherland highlights how Revi®’s daily use boosts efficacy for urge urinary incontinence (#UUI), with data to back the positive results! Learn more: https://lnkd.in/e-PYjrdf #urology #PatientCare #urogyn #OAB

Living with urge urinary incontinence (#UUI) means facing constant disruptions, whether it’s sleepless nights or planning every outing around a bathroom. Revi® is here to help — providing a long-term solution that allows your bladder to relax so you can, too. Revi can help you reclaim control and live life on your own terms: https://lnkd.in/e6V7ugaz #Urology #OAB #PatientCare

Revi® is here to support everyone managing urge urinary incontinence (#UUI), including our Spanish-speaking community. Our downloadable Spanish guides offer essential information on treatment options, lifestyle tips, and steps to see if Revi is right for you. Learn more: https://lnkd.in/edPAASPE #Urology #PatientCare

We are excited to announce Michael Ehlert of Minnesota Urology of the Minneapolis-Saint Paul area has performed his first #Revi procedure, a transformative new treatment for patients suffering with urgency urinary #incontinence. Thank you for your commitment to advancing healthcare and to improving patients’ quality of life! #iTNM #Revi #urinaryincontinence

Revi® is advancing the way we treat urge urinary incontinence (#UUI), providing safe, effective results that enhance patient quality of life. Backed by the OASIS pivotal study, Revi offers a patient-centered approach to UUI care with strong clinical outcomes. Dive into our latest publications for more on how Revi is helping patients and shaping the future of #Urology. https://lnkd.in/dD4YBEcn

🎥 Check out Dr. Laura Giusto’s key insights for physicians who want to know more about performing tibial nerve implants for urgency urinary incontinence (UUI).   Dr. Giusto highlights how our hands-on training helps make the procedure simple and reproducible, ensuring the best outcomes for patients.   Learn more: https://lnkd.in/eDq8Kv73     #Urology #Urogyn

This #Thanksgiving, we’re especially #thankful for the opportunity to make a real difference in the lives of those managing urgency urinary incontinence (UUI). Wishing you and your patients a happy and healthy holiday. #Urology #Urogyn #HappyHolidays